Financials
- Market Capitalization 39.92 M
- Employee 39
- Founded 2015
- CEO Denise Scots-Knight
- Website www.mereobiopharma.com
- Headquarter United Kingdom
- FIGI BBG00KFWZC67
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-8.33
ratio cours/chiffre d'affaires
664.32
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4305 | EDSA Edesa Biotech, Inc. - Common Shares | 4.62 USD | +0.43% | +3.82% | -12.67% | +92.50% | 44.54 M USD | ||
| 4327 | KPTI Karyopharm Therapeutics Inc. - Common Stock | 1.87 USD | -3.61% | -4.10% | -73.21% | -80.60% | 42.41 M USD | ||
| 4345 | ACTU Actuate Therapeutics, Inc. - Common stock | 1.66 USD | -1.78% | +29.69% | +52.29% | -59.31% | 39.86 M USD | ||
| 4354 | CRVO CervoMed Inc. - Common Stock | 2.60 USD | -1.52% | -1.89% | +5.26% | -73.06% | 39.31 M USD |